On December 30, 2021, it was jointly organized by Guangdong Manufacturing Association, Guangdong Industrial Development and Reform Research Institute, Industrial Economic Research Institute of Jinan University, Guangdong Provincial Department of Industry and Information Technology, Guangdong Provincial Department of Commerce, and Guangdong Provincial Development and Reform Commission. The "2021 Guangdong Manufacturing Development Annual Conference and Guangdong Top 500 Manufacturing Enterprise Summit" was held in Guangzhou. With the competitiveness and influence of high-quality development, Guangzhou Hairui Pharmaceutical has been selected for the 2021 "Top 500 Manufacturing Industry in Guangdong Province" for six consecutive years, ranking 220th (all fields), up 63 places from last year, and 11th in the pharmaceutical industry bit.

The top 500 manufacturing enterprises in Guangdong are the leaders of Guangdong's manufacturing industry, driving the development of the entire industry and the industrial chain, and are the main force for the steady development of the province's manufacturing industry. In recent years, Guangzhou Hairui Pharmaceutical Co., Ltd. has been facing the complex pharmaceutical industry situation and transformed to high-quality development through innovation empowerment. The new products Fasudil Hydrochloride Injection, Thymosin for Injection, Parecoxib Sodium for Injection, Atosiban Acetate Injection, Ticagrelor Tablets, Rivaroxaban Tablets, Clopidogrel Hydrogen Sulfate Tablets and more than ten blockbuster varieties have been approved for the market one after another. In 2021, 6 items of consistency evaluation varieties have been approved (deemed to have passed), ranking among the top companies in Guangdong Province that have passed the consistency evaluation of generic drugs.

Come back with honor, take advantage of the momentum! Guangzhou Hairui Pharmaceutical will closely follow the pace of the Group's "14th Five-Year Plan" development strategy, practice the corporate mission of "seeking, enterprising and protecting all living beings", and is determined to take the road of high-quality and sustainable development, adhere to reform and innovation, focus on innovative drugs, The research and development and industrialization of traditional Chinese medicines and biological medicines will realize comprehensive transformation and upgrading, promote the high-quality development of enterprises, and help the group to move towards the goal of becoming a world-class pharmaceutical enterprise.